Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 16, 2015 - Issue 13
Submit an article Journal homepage
459
Views
22
CrossRef citations to date
0
Altmetric
Drug Evaluation

Apremilast for the treatment of psoriasis

Maria Sole ChimentiUniversity of Rome “Tor Vergata”, Rheumatology, Allergology and Clinical Immunology, Rome, Italy
,
Talia GramicciaUniversity of Rome “Tor Vergata”, Dermatology, V.le Oxford 81, 00133, Rome, Italy+39 33 9566 8320; +39 06 2090 2742; [email protected]
,
Rosita SaracenoUniversity of Rome “Tor Vergata”, Dermatology, V.le Oxford 81, 00133, Rome, Italy+39 33 9566 8320; +39 06 2090 2742; [email protected]
,
Luca BianchiUniversity of Rome “Tor Vergata”, Dermatology, V.le Oxford 81, 00133, Rome, Italy+39 33 9566 8320; +39 06 2090 2742; [email protected]
,
Virginia GarofaloUniversity of Rome “Tor Vergata”, Dermatology, V.le Oxford 81, 00133, Rome, Italy+39 33 9566 8320; +39 06 2090 2742; [email protected]
,
Oreste BuonomoUniversity of Rome Tor Vergata, Department of Surgery, Rome, Italy
,
Roberto PerriconeUniversity of Rome “Tor Vergata”, Rheumatology, Allergology and Clinical Immunology, Rome, Italy
,
Sergio ChimentiUniversity of Rome “Tor Vergata”, Dermatology, V.le Oxford 81, 00133, Rome, Italy+39 33 9566 8320; +39 06 2090 2742; [email protected]
, MD &
Andrea ChiricozziUniversity of Rome “Tor Vergata”, Dermatology, V.le Oxford 81, 00133, Rome, Italy+39 33 9566 8320; +39 06 2090 2742; [email protected]
 show all
Pages 2083-2094 | Published online: 04 Aug 2015

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Maria Sole Chimenti, Arianna D’Antonio, Paola Conigliaro, Sara Ferrigno, Andrea Vendola, Mario Ferraioli, Paola Triggianese, Luisa Costa, Francesco Caso & Roberto Perricone. (2020) An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis. Biologics: Targets and Therapy 14, pages 53-75.
Read now
Francesco Caso, Luca Navarini, Piero Ruscitti, Maria Sole Chimenti, Nicolò Girolimetto, Antonio Del Puente, Roberto Giacomelli, Raffaele Scarpa & Luisa Costa. (2020) Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art. Expert Opinion on Pharmacotherapy 21:7, pages 785-796.
Read now
Masutaka Furue, Takafumi Kadono, Gaku Tsuji & Takeshi Nakahara. (2017) Topical E6005/RVT-501, a novel phosphodiesterase 4 inhibitor, for the treatment of atopic dermatitis. Expert Opinion on Investigational Drugs 26:12, pages 1403-1408.
Read now
Uwe Wollina. (2017) Emerging treatments for pyoderma gangrenosum. Expert Opinion on Orphan Drugs 5:10, pages 827-832.
Read now
Luca Bianchi, Ester Del Duca, Marco Romanelli, Rosita Saraceno, Sergio Chimenti & Andrea Chiricozzi. (2016) Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis. Expert Opinion on Drug Metabolism & Toxicology 12:9, pages 1121-1128.
Read now
Abraham M. Korman, Dane Hill, Ali Alikhan & Steven R. Feldman. (2016) Oral tofacitinib for the treatment of adults with moderate to severe chronic plaque psoriasis. Expert Review of Clinical Pharmacology 9:4, pages 525-539.
Read now

Articles from other publishers (16)

Fahad Sami Alfehaid, Anroop B. Nair, Hiral Shah, Bandar Aldhubiab, Jigar Shah, Vivek Mewada, Shery Jacob & Mahesh Attimarad. (2024) Enhanced transdermal delivery of apremilast loaded ethosomes: Optimization, characterization and in vivo evaluation. Journal of Drug Delivery Science and Technology 91, pages 105211.
Crossref
Gaetano LICATA, Vittorio TANCREDI, Alessio GAMBARDELLA, Matteo MEGNA, Gabriella FABBROCINI, Annunziata RAIMONDO, Serena LEMBO, Luigi LIGRONE, Francesco CUSANO & Giuseppe ARGENZIANO. (2023) Efficacy, tolerability and patient's satisfaction for the treatment of moderate to severe plaque psoriasis with apremilast in the real-life setting of Campania region, Italy. Italian Journal of Dermatology and Venereology 158:6.
Crossref
Franziska Vielmuth, Mariya Y. Radeva, Sunil Yeruva, Anna M. Sigmund & Jens Waschke. (2023) cAMP : A master regulator of cadherin‐mediated binding in endothelium, epithelium and myocardium . Acta Physiologica.
Crossref
Mingyuan Wang, Xiangyuan Meng & Zhihua Cheng. (2022) Apremilast exerts protective effects on stroke outcomes and blood–brain barrier (BBB) dysfunction through regulating Rho‐associated protein kinase 2 expression. Brain and Behavior 12:9.
Crossref
Prashansha Mullick, Sadhana P Mutalik, Aswathi R Hegde, Abhijeet Pandey, P C Jagadish, Suvarna G Kini, Sanyog Jain & Srinivas Mutalik. (2021) Simultaneous Estimation of Apremilast and Betamethasone Dipropionate in Microsponge-Based Topical Formulation using a Stability Indicating RP-HPLC Method: A Quality-by-Design Approach. Journal of Chromatographic Science 59:10, pages 928-940.
Crossref
Alexander Nast, Andreas Altenburg, Matthias Augustin, Wolf‐Henning Boehncke, Peter Härle, Joachim Klaus, Joachim Koza, Ulrich Mrowietz, Hans‐Michael Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Martin Schlaeger, Gerhard Schmid‐Ott, Michael Sebastian, Ralph Kiedrowski, Tobias Weberschock & Corinna Dressler. (2021) Deutsche S3‐Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidität. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:7, pages 1092-1117.
Crossref
Alexander Nast, Andreas Altenburg, Matthias Augustin, Wolf‐Henning Boehncke, Peter Härle, Joachim Klaus, Joachim Koza, Ulrich Mrowietz, Hans‐Michael Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Martin Schlaeger, Gerhard Schmid‐Ott, Michael Sebastian, Ralph Kiedrowski, Tobias Weberschock & Corinna Dressler. (2021) German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 2: Treatment monitoring and specific clinical or comorbid situations. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:7, pages 1092-1115.
Crossref
A. Nast, C. Smith, P.I. Spuls, G. Avila Valle, Z. Bata‐Csörgö, H. Boonen, E. De Jong, I. Garcia‐Doval, P. Gisondi, D. Kaur‐Knudsen, S. Mahil, T. Mälkönen, J.T. Maul, S. MburuU. Mrowietz, K. Reich, E. Remenyik, K.M. Rønholt, P.G. Sator, M. Schmitt‐Egenolf, M. Sikora, K. Strömer, O. Sundnes, D. TrigosG. Van Der Kraaij, N. Yawalkar & C. Dressler. (2021) EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations. Journal of the European Academy of Dermatology and Venereology 35:2, pages 281-317.
Crossref
YuFei He, Yadan Huang, ChuTian Mai, Hudan Pan, Hai-Bin Luo, Liang Liu & Ying Xie. (2020) The immunomodulatory role of PDEs inhibitors in immune cells: therapeutic implication in rheumatoid arthritis. Pharmacological Research 161, pages 105134.
Crossref
Carla R.A. Batista, Adriana M. Godin, Ivo S.F. Melo, Giovanna M.E. Coura, Tamires C. Matsui, Marcela M.G.B. Dutra, Ana Mercy S. Brito, Wagner G. Canhestro, Ricardo J. Alves, Débora P. Araújo, Ângelo de Fátima, Renes R. Machado & Márcio M. Coelho. (2019) The phthalimide analogues N-3-hydroxypropylphthalimide and N-carboxymethyl-3-nitrophthalimide exhibit activity in experimental models of inflammatory and neuropathic pain. Pharmacological Reports 71:6, pages 1177-1183.
Crossref
Sari Okazaki, Risa Osawa, Hideki Nakajima, Kimiko Nakajima & Shigetoshi Sano. (2019) Favorable response to apremilast in a patient with refractory psoriasis verrucosa. The Journal of Dermatology 46:6, pages 544-547.
Crossref
A. Nast, P.I. Spuls, G. van der Kraaij, P. Gisondi, C. Paul, A.D. Ormerod, P. Saiag, C.H. Smith, E. Dauden, E.M. de Jong, E. Feist, R. Jobling, M. Maccarone, U. Mrowietz, K.A. Papp, K. Reich, S. Rosumeck, T. Talme, H.B. Thio, P. van de Kerkhof, R.N. Werner & C. Dressler. (2017) European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC. Journal of the European Academy of Dermatology and Venereology 31:12, pages 1951-1963.
Crossref
Thomas G. Salopek. (2017) Recurrence of Melanoma after Starting Apremilast for Psoriasis. Case Reports in Dermatology 9:2, pages 108-111.
Crossref
Daniel J. No, Kavita Darji, Mina Amin & Jashin J. Wu. 2017. Clinical Cases in Psoriasis. Clinical Cases in Psoriasis 133 141 .
Daniel J. No, Mina Amin, Kavita Darji & Jashin J. Wu. 2017. Clinical Cases in Psoriasis. Clinical Cases in Psoriasis 117 126 .
Richard Duong & Matthew Gilbert. (2016) Psoriasis: Overview, recent approvals, therapies on the horizon. Pharmacy Today 22:1, pages 44-45.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.